Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic × idelalisib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 7 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Waldenstrom Macroglobulinemia 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, B-Cell 1 Leukemia 1 Hematologic Diseases 1 B-cell Malignancies 1

Interventions

fludarabine 6 Whole-Body Irradiation 6 Cyclophosphamide 6 Mycophenolic Acid 5 fludarabine phosphate 4 ibrutinib 3 Sirolimus 3 Cyclosporine 3 acalabrutinib 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Cyclosporins 2 venetoclax 1 treosulfan 1 tafasitamab 1 selinexor 1 obinutuzumab 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Stem Cell Transplantation 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Patient Reported Outcome Measures 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡